Indaptus Therapeutics, Inc.

NASDAQ:INDP

Biotechnology

Healthcare
$3.29 -2.21%

-$0.03 today

Market cap
$372.57M
Beta
1.14
P/E (TTM)
-0.2
EPS (TTM)
-$8.70
52W Low $0.92High $8.69

Volume 0.17M

Average 0.97M

Balance Sheet

Inspect the capital base behind the business.

Assets

$9.31M

FY 2025 · Annual

+26.9% YoY

Liabilities

$6.16M

FY 2025 · Annual

+81.5% YoY

Equity

$3.15M

FY 2025 · Annual

-20.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents39.13M9.63M13.36M5.79M8.51M
Short-term Investments016.81M000
Net Receivables21.06K0000
Inventory00000
Other Current Assets148.4K0000
Total Current Assets40.39M27.24M14M6.62M9.31M
Property, Plant & Equipment (Net)172.89K81.31K173.94K82.18K0
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets16.48K738.25K754.73K638.25K0
Total Non-current Assets189.37K819.56K928.67K720.43K0
Total Assets40.58M28.06M14.92M7.34M9.31M
Account Payables2.64M1.38M806K870.23K544.06K
Short-term Debt00000
Tax Payables0128.93K40K00
Deferred Revenue00000
Other Current Liabilities498.73K1.22M1.21M1.37M4.03M
Total Current Liabilities4.6M3.43M2.77M3.39M6.16M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities72.86K073.35K00
Total Liabilities4.68M3.43M2.85M3.39M6.16M
Common Stock82.59K84.01K84.01K120.14K21.67K
Retained Earnings(15.67M)(29.99M)(45.42M)(60.44M)(81.29M)
Accumulated OCI096.43K000
Other Stockholders Equity00000
Minority Interest00000
Total Equity35.9M24.63M12.08M3.94M3.15M
Total Debt169.33K80.49K175.05K84.16K0
Net Debt(38.96M)(9.55M)(13.19M)(5.7M)(8.51M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$1.5M
Other Current$683.2K
Total Current Assets$2.2M
Total Assets$2.2M

Analysis

Selected assets total $2.2M for Latest. The largest visible component is Cash & Equivalents at $1.5M, about 68.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13D/ASC 13D/A filingOct 22, 2026
SC 13D/ASC 13D/A filingOct 22, 2026
SC 13D/ASC 13D/A filingOct 22, 2026

How much cash does INDP have?

Indaptus Therapeutics, Inc. (INDP) reported $8.51M in cash and equivalents in fiscal 2025.

How much debt does INDP carry?

Indaptus Therapeutics, Inc. (INDP) reported $0.00 of total debt, with net debt of -$8.51M.